Literature DB >> 18464595

[Structure and function of angiotensin converting enzyme and its inhibitors].

Yulan Zhao1, Chuanlian Xu.   

Abstract

Angiotensin converting enzyme (ACE, EC 3.4.15.1) is a membrane-bound, zinc dependent dipeptidase that catalyzes the conversion of the decapeptide angiotensin I to the potent vasopressor ocatapeptide angiotensin II, by removing two C-terminal amino acids. ACE is well known as a key part of the renin angiotenisn system that regulates blood pressure, and its inhibitors have potential for the treatment of hypertension. This paper reviewed the characteristics of ACE in aspects of its structure-function relationship, gene polymorphism and inhibitor development. In particular, the catalytic mechanisms of the two active sites of somatic ACE in the cleavage of angiotensin I and bradykin are different. Therefore, it would likely provide a new way for exploiting novel ACE inhibitors with fewer side-effects by specifically-targeting the individual active sites of somatic ACE.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18464595      PMCID: PMC7148949          DOI: 10.1016/s1872-2075(08)60007-2

Source DB:  PubMed          Journal:  Sheng Wu Gong Cheng Xue Bao        ISSN: 1000-3061


  29 in total

1.  The II genotype of the angiotensin-converting enzyme gene delays the onset of acute coronary syndromes.

Authors:  N Iwai; S Tamaki; N Ohmichi; M Kinoshita
Journal:  Arterioscler Thromb Vasc Biol       Date:  1997-09       Impact factor: 8.311

2.  RXP 407, a selective inhibitor of the N-domain of angiotensin I-converting enzyme, blocks in vivo the degradation of hemoregulatory peptide acetyl-Ser-Asp-Lys-Pro with no effect on angiotensin I hydrolysis.

Authors:  C Junot; M F Gonzales; E Ezan; J Cotton; G Vazeux; A Michaud; M Azizi; S Vassiliou; A Yiotakis; P Corvol; V Dive
Journal:  J Pharmacol Exp Ther       Date:  2001-05       Impact factor: 4.030

3.  RXP 407, a phosphinic peptide, is a potent inhibitor of angiotensin I converting enzyme able to differentiate between its two active sites.

Authors:  V Dive; J Cotton; A Yiotakis; A Michaud; S Vassiliou; J Jiracek; G Vazeux; M T Chauvet; P Cuniasse; P Corvol
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-13       Impact factor: 11.205

Review 4.  Rethinking the renin-angiotensin system and its role in cardiovascular regulation.

Authors:  Pasquale Pagliaro; Claudia Penna
Journal:  Cardiovasc Drugs Ther       Date:  2005-01       Impact factor: 3.727

5.  Molecular cloning of human testicular angiotensin-converting enzyme: the testis isozyme is identical to the C-terminal half of endothelial angiotensin-converting enzyme.

Authors:  M R Ehlers; E A Fox; D J Strydom; J F Riordan
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

6.  Angiotensin converting enzyme and the arrhythmogenic action of angiotensin I: cardiac cell membrane as a site of angiotensin I conversion.

Authors:  Walmor C De Mello
Journal:  Regul Pept       Date:  2004-09-15

7.  Angiotensin converting enzyme I/D, angiotensinogen T174M-M235T and angiotensin II type 1 receptor A1166C gene polymorphisms in Turkish hypertensive patients.

Authors:  Bedia Agachan; Turgay Isbir; Hulya Yilmaz; Emel Akoglu
Journal:  Exp Mol Med       Date:  2003-12-31       Impact factor: 8.718

Review 8.  Using ACE inhibitors appropriately.

Authors:  Daphne P Bicket
Journal:  Am Fam Physician       Date:  2002-08-01       Impact factor: 3.292

9.  Emodin blocks the SARS coronavirus spike protein and angiotensin-converting enzyme 2 interaction.

Authors:  Tin-Yun Ho; Shih-Lu Wu; Jaw-Chyun Chen; Chia-Cheng Li; Chien-Yun Hsiang
Journal:  Antiviral Res       Date:  2006-05-15       Impact factor: 5.970

10.  Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus.

Authors:  Wenhui Li; Michael J Moore; Natalya Vasilieva; Jianhua Sui; Swee Kee Wong; Michael A Berne; Mohan Somasundaran; John L Sullivan; Katherine Luzuriaga; Thomas C Greenough; Hyeryun Choe; Michael Farzan
Journal:  Nature       Date:  2003-11-27       Impact factor: 49.962

View more
  1 in total

1.  Exploring the molecular complexity of Triatoma dimidiata sialome.

Authors:  Paula Beatriz Santiago; Carla Nunes de Araújo; Sébastien Charneau; Izabela Marques Dourado Bastos; Teresa Cristina F Assumpção; Rayner Myr Lauterjung Queiroz; Yanna Reis Praça; Thuany de Moura Cordeiro; Carlos Henrique Saraiva Garcia; Ionizete Garcia da Silva; Tainá Raiol; Flávia Nader Motta; João Victor de Araújo Oliveira; Marcelo Valle de Sousa; José Marcos C Ribeiro; Jaime Martins de Santana
Journal:  J Proteomics       Date:  2017-12-27       Impact factor: 4.044

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.